The prevalence of germ-line TP53 mutations in women diagnosed with breast cancer before age 30

Ophira M. Ginsburg, Mohammad R. Akbari, Zeba Aziz, Robert Young, Henry T. Lynch, Parviz Ghadirian, Andre Robidoux, Julian Londono, Gonzalo Vasquez, Magda Gomes, Mauricio Magalhaes Costa, Constantine Dimitrakakis, Gustavo Gutierrez, Robert Pilarski, Robert Royer, Steven A. Narod

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Germ-line mutations in the TP53 gene are rare, but predispose women to a range of cancer types, including early-onset breast cancer. Breast cancers in women from families with the Li-Fraumeni syndrome often occur before age 30. The prevalence of deleterious TP53 mutations in unselected women with early-onset breast cancer is not precisely known. If mutations were found to be sufficiently common, it might be prudent to offer genetic testing to affected women in this age group. We screened the entire TP53 gene in the germ-line DNA from 95 women of various ethnic groups who were diagnosed with breast cancer before age 30, and who had previously been found to be negative for BRCA1 and BRCA2 mutations. No TP53 mutation was found. This study does not support a policy that TP53 testing should be offered routinely to unselected women with early-onset breast cancer in the absence of a family history of cancer.

Original languageEnglish
Pages (from-to)563-567
Number of pages5
JournalFamilial Cancer
Volume8
Issue number4
DOIs
StatePublished - Dec 2009

Fingerprint

Germ-Line Mutation
Breast Neoplasms
Mutation
p53 Genes
Li-Fraumeni Syndrome
Genetic Testing
Ethnic Groups
Germ Cells
Neoplasms
Age Groups
DNA

All Science Journal Classification (ASJC) codes

  • Cancer Research
  • Genetics
  • Oncology
  • Genetics(clinical)

Cite this

Ginsburg, O. M., Akbari, M. R., Aziz, Z., Young, R., Lynch, H. T., Ghadirian, P., ... Narod, S. A. (2009). The prevalence of germ-line TP53 mutations in women diagnosed with breast cancer before age 30. Familial Cancer, 8(4), 563-567. https://doi.org/10.1007/s10689-009-9287-z

The prevalence of germ-line TP53 mutations in women diagnosed with breast cancer before age 30. / Ginsburg, Ophira M.; Akbari, Mohammad R.; Aziz, Zeba; Young, Robert; Lynch, Henry T.; Ghadirian, Parviz; Robidoux, Andre; Londono, Julian; Vasquez, Gonzalo; Gomes, Magda; Costa, Mauricio Magalhaes; Dimitrakakis, Constantine; Gutierrez, Gustavo; Pilarski, Robert; Royer, Robert; Narod, Steven A.

In: Familial Cancer, Vol. 8, No. 4, 12.2009, p. 563-567.

Research output: Contribution to journalArticle

Ginsburg, OM, Akbari, MR, Aziz, Z, Young, R, Lynch, HT, Ghadirian, P, Robidoux, A, Londono, J, Vasquez, G, Gomes, M, Costa, MM, Dimitrakakis, C, Gutierrez, G, Pilarski, R, Royer, R & Narod, SA 2009, 'The prevalence of germ-line TP53 mutations in women diagnosed with breast cancer before age 30', Familial Cancer, vol. 8, no. 4, pp. 563-567. https://doi.org/10.1007/s10689-009-9287-z
Ginsburg, Ophira M. ; Akbari, Mohammad R. ; Aziz, Zeba ; Young, Robert ; Lynch, Henry T. ; Ghadirian, Parviz ; Robidoux, Andre ; Londono, Julian ; Vasquez, Gonzalo ; Gomes, Magda ; Costa, Mauricio Magalhaes ; Dimitrakakis, Constantine ; Gutierrez, Gustavo ; Pilarski, Robert ; Royer, Robert ; Narod, Steven A. / The prevalence of germ-line TP53 mutations in women diagnosed with breast cancer before age 30. In: Familial Cancer. 2009 ; Vol. 8, No. 4. pp. 563-567.
@article{189cfddab02b4062ac70bfe15b9f2dc2,
title = "The prevalence of germ-line TP53 mutations in women diagnosed with breast cancer before age 30",
abstract = "Germ-line mutations in the TP53 gene are rare, but predispose women to a range of cancer types, including early-onset breast cancer. Breast cancers in women from families with the Li-Fraumeni syndrome often occur before age 30. The prevalence of deleterious TP53 mutations in unselected women with early-onset breast cancer is not precisely known. If mutations were found to be sufficiently common, it might be prudent to offer genetic testing to affected women in this age group. We screened the entire TP53 gene in the germ-line DNA from 95 women of various ethnic groups who were diagnosed with breast cancer before age 30, and who had previously been found to be negative for BRCA1 and BRCA2 mutations. No TP53 mutation was found. This study does not support a policy that TP53 testing should be offered routinely to unselected women with early-onset breast cancer in the absence of a family history of cancer.",
author = "Ginsburg, {Ophira M.} and Akbari, {Mohammad R.} and Zeba Aziz and Robert Young and Lynch, {Henry T.} and Parviz Ghadirian and Andre Robidoux and Julian Londono and Gonzalo Vasquez and Magda Gomes and Costa, {Mauricio Magalhaes} and Constantine Dimitrakakis and Gustavo Gutierrez and Robert Pilarski and Robert Royer and Narod, {Steven A.}",
year = "2009",
month = "12",
doi = "10.1007/s10689-009-9287-z",
language = "English",
volume = "8",
pages = "563--567",
journal = "Familial Cancer",
issn = "1389-9600",
publisher = "Springer Netherlands",
number = "4",

}

TY - JOUR

T1 - The prevalence of germ-line TP53 mutations in women diagnosed with breast cancer before age 30

AU - Ginsburg, Ophira M.

AU - Akbari, Mohammad R.

AU - Aziz, Zeba

AU - Young, Robert

AU - Lynch, Henry T.

AU - Ghadirian, Parviz

AU - Robidoux, Andre

AU - Londono, Julian

AU - Vasquez, Gonzalo

AU - Gomes, Magda

AU - Costa, Mauricio Magalhaes

AU - Dimitrakakis, Constantine

AU - Gutierrez, Gustavo

AU - Pilarski, Robert

AU - Royer, Robert

AU - Narod, Steven A.

PY - 2009/12

Y1 - 2009/12

N2 - Germ-line mutations in the TP53 gene are rare, but predispose women to a range of cancer types, including early-onset breast cancer. Breast cancers in women from families with the Li-Fraumeni syndrome often occur before age 30. The prevalence of deleterious TP53 mutations in unselected women with early-onset breast cancer is not precisely known. If mutations were found to be sufficiently common, it might be prudent to offer genetic testing to affected women in this age group. We screened the entire TP53 gene in the germ-line DNA from 95 women of various ethnic groups who were diagnosed with breast cancer before age 30, and who had previously been found to be negative for BRCA1 and BRCA2 mutations. No TP53 mutation was found. This study does not support a policy that TP53 testing should be offered routinely to unselected women with early-onset breast cancer in the absence of a family history of cancer.

AB - Germ-line mutations in the TP53 gene are rare, but predispose women to a range of cancer types, including early-onset breast cancer. Breast cancers in women from families with the Li-Fraumeni syndrome often occur before age 30. The prevalence of deleterious TP53 mutations in unselected women with early-onset breast cancer is not precisely known. If mutations were found to be sufficiently common, it might be prudent to offer genetic testing to affected women in this age group. We screened the entire TP53 gene in the germ-line DNA from 95 women of various ethnic groups who were diagnosed with breast cancer before age 30, and who had previously been found to be negative for BRCA1 and BRCA2 mutations. No TP53 mutation was found. This study does not support a policy that TP53 testing should be offered routinely to unselected women with early-onset breast cancer in the absence of a family history of cancer.

UR - http://www.scopus.com/inward/record.url?scp=70449532098&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70449532098&partnerID=8YFLogxK

U2 - 10.1007/s10689-009-9287-z

DO - 10.1007/s10689-009-9287-z

M3 - Article

VL - 8

SP - 563

EP - 567

JO - Familial Cancer

JF - Familial Cancer

SN - 1389-9600

IS - 4

ER -